News

BBC Studios Distribution Limited, company number 01420028, 1 Television Centre, 101 Wood Lane, London, United Kingdom, W12 ...
Wegovy is now approved by the FDA to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced fibrosis ...
Move over Downton Abbey, Harry Potter and Paddington Bear - as Chinese inflencers were left shocked by all the things they ...
Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s ...
The drug received accelerated approval for use in patients with metabolic dysfunction-associated steatohepatitis (MASH).
"Madrigal wins European MASH approval as Novo rivalry looms" was originally created and published by Pharmaceutical ...
Madrigal Pharmaceuticals MDGL announced that the European Commission (EC) has granted a conditional marketing authorization ...
The label expansion could help Novo Nordisk “help shift the momentum” for Wegovy, after a difficult start to 2025, according ...
Madrigal Pharmaceuticals ( NASDAQ: MDGL) has received conditional marketing approval from the European Commission for ...
The FDA clearance sets Novo’s medicine up for a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.
Fans of iconic '80s sitcoms and beloved animated series were in for a treat on Wednesday when one of its biggest stars ...
Novo Nordisk's GLP-1 drugs have been under considerable competitive pressure in the last few months, so the company will be ...